Drug recall
Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bottles, Rx Only, Apotex Corp…
FDA recall event 72118 · Class III · Apotex Inc.
Key facts
| Event ID | 72118 |
|---|---|
| Recall numbers | D1834-2015 |
| Recalling firm | Apotex Inc. |
| Product type | Drugs |
| Products | Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bottles, Rx Only, Apotex Corp. Manufactured by Apotex Research Private Limited, Bangalore, Karnataka 560 099, India… |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Failed Dissolution Specification: One lot of product did not meet the first stage dissolution specification limits. |
| Initiation date | Jul 21, 2015 |
| Report date | Oct 7, 2015 |
| Termination date | Feb 15, 2017 |
| City | Toronto |
| Country | Canada |
| FEI number | 3002906944 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: